1 / 6

NVAC Pandemic Influenza Working Group (PIWG): Objectives, Process, and Outcomes

NVAC Pandemic Influenza Working Group (PIWG): Objectives, Process, and Outcomes. HHS Pandemic Influenza Preparedness & Response Planning. Draft preparedness and response plan released by HHS on August 26, 2004 Public comments (~40) received during 60-day comment period

ilori
Download Presentation

NVAC Pandemic Influenza Working Group (PIWG): Objectives, Process, and Outcomes

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. NVAC Pandemic Influenza Working Group (PIWG): Objectives, Process, and Outcomes

  2. HHS Pandemic Influenza Preparedness & Response Planning • Draft preparedness and response plan released by HHS on August 26, 2004 • Public comments (~40) received during 60-day comment period • NVAC comments provided at October 2004 meeting • Need to address issue of pandemic vaccine purchase • Need to provide additional guidance on priority groups for antiviral drugs and vaccines • Need to resolve liability protection issue

  3. The NVAC Pandemic Influenza Working Group • Participants • NVAC members • Representatives of stakeholder organizations • Federal agencies and advisory committees • Public health organizations • Medical professional societies • Health care organizations • Ethicists • Public Health Agency of Canada • Consultants from vaccine and antiviral industry, and influenza experts from academia

  4. Objectives of the NVAC Pandemic Influenza Working Group • Assess options and provide comments on critical issues leading toward NVAC/ACIP recommendations • Vaccine & antiviral purchase • Vaccine priority groups – jointly with ACIP • Antiviral priority groups and strategies • Increase engagement with key stakeholders • Address other issues, as needed

  5. Pandemic Influenza Working Group Process • Pandemic vaccine purchase • Discussion of options by the PIWG (led by Dr. Orenstein) • Vaccine priority groups • Joint subgroup of NVAC/ACIP (chaired by Drs. Freed and Allos) • Antiviral priority groups and strategies • Subgroup of NVAC (chaired by Dr. Pavia)

  6. NVAC PIWG & Joint NVAC/ACIP Vaccine Subgroup Timeline • April 19-20 – Initial PIWG, and vaccine and antiviral subgroup meetings • Ongoing – working groups consider issues relevant to priority setting tasks • Impacts and risk groups in past pandemics • Stratification of health care workers • Definition of essential workers • June 15-16 – Meetings of vaccine & antiviral subgroups (Atlanta) • June 29-30 – Presentation of vaccine priority group options to ACIP • July 19 – Presentation of vaccine & antiviral priority group options and strategies to NVAC

More Related